Polymorphisms in folate-related genes and risk of pediatric acute lymphoblastic leukemia
Open Access
- 5 March 2009
- journal article
- Published by American Society of Hematology in Blood
- Vol. 113 (10), 2284-2289
- https://doi.org/10.1182/blood-2008-07-165928
Abstract
Polymorphisms in folate pathway genes may influence the susceptibility to acute lymphoblastic leukemia (ALL). DNA was isolated from 245 pediatric ALL patients (cases) and from 500 blood bank donors (controls). Polymorphisms in methylene-tetrahydrofolate reductase (MTHFR 677C>T, 1298A>C), methionine synthase (MTR 2756A>G), methionine synthase reductase (MTRR 66A>G), methylenetetrahydrofolate dehydrogenase (MTHFD1 1958G>A), nicotinamide N-methyltransferase (NNMT IVS −151C>T), serine hydroxymethyl transferase (SHMT1 1420C>T), thymidylate synthase (TS 2R3R), and the reduced folate carrier (RFC1 80G>A) were detected. In ALL patients, an increased occurrence was observed of the RFC1 80AA variant (odds ratio [OR] = 2.1; 95% confidence interval [CI] = 1.3-3.2; P = .002) and the RFC1 80A allele (OR = 1.5; 95% CI, 1.1-2.1; P = .02). Likewise, the NNMT IVS −151TT genotype showed a 2.2-fold increased ALL risk (OR = 2.2; 95% CI, 1.1-4.6; P = .04). A 1.4-fold reduction in ALL risk was observed for (heterozygous or homozygous) carriers of the TS 2R allele and the MTHFR 677T allele (OR = 0.7; 95% CI, 0.5-1.0; P < .05). Furthermore, interactions between NNMT and MTHFR 677C>T and RFC1 were observed. NNMT IVS −151CC/MTHFR 677CT + TT patients exhibited a 2-fold reduction in ALL risk whereas RFC1 80AA/NNMT IVS −151CT + TT subjects had a 4.2-fold increase in ALL risk (P = .001). For the first time, we associate the RFC1 80G>A and NNMT IVS −151C>T variants to an increased ALL susceptibility.This publication has 50 references indexed in Scilit:
- Meta- and Pooled Analyses of the Methylenetetrahydrofolate Reductase C677T and A1298C Polymorphisms and Gastric Cancer Risk: A Huge-GSEC ReviewAmerican Journal of Epidemiology, 2007
- Gene polymorphisms of folate metabolizing enzymes and the risk of gastric cancerCancer Letters, 2007
- MTHFR and RFC‐1 gene polymorphisms and the risk of Down syndrome in Italy. Author's response to the comments by Scala et al. [2007]American Journal of Medical Genetics Part A, 2007
- Ancestry and pharmacogenetics of antileukemic drug toxicityBlood, 2007
- 5,10-Methylenetetrahydrofolate Reductase Polymorphisms and Acute Lymphoblastic Leukemia Risk: A Meta-analysisCancer Epidemiology, Biomarkers & Prevention, 2006
- G80A reduced folate carrier SNP modulates cellular uptake of folate and affords protection against thrombosis via a non homocysteine related mechanismLife Sciences, 2005
- A Genomewide Exploration Suggests a New Candidate Gene at Chromosome 11q23 as the Major Determinant of Plasma Homocysteine Levels: Results from the GAIT ProjectAmerican Journal of Human Genetics, 2005
- Is folic acid the ultimate functional food component for disease prevention?BMJ, 2004
- Role of MTHFR genetic polymorphisms in the susceptibility to childhood acute lymphoblastic leukemiaBlood, 2004
- A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductaseNature Genetics, 1995